SAN FRANCISCO - Nurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company specializing in targeted protein modulation drugs, announced today the appointment of John Northcott as its new ...

Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia ...

A new ICMR study reveals one in nine Indians is at risk of cancer. Lung and breast cancers are the most common, with lymphoid ...

Heather Bouwman has two children in their 20s and a new book — “Scattergood,” out Jan. 21 — that is technically older than both of them. The University of St. Thomas creative writing professor, who ...

Probably the only reasonable response to such a speech.

Glycolysis is a central metabolic pathway by which cells obtain energy from sugar. Cancer cells in particular have long been ...

Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes ...

New data suggest venetoclax may offset the negative prognostic impact of short telomeres in patients with chronic lymphocytic ...

In an interview, Paolo Ghia, MD, PhD, discussed updated data from the phase 2 CAPTIVATE trial of ibrutinib and venetoclax in ...

The following is a summary of “Critically ill adult patients with acute leukemia: a systematic review and meta-analysis,” published in the January 2025 issue of Critical Care by Chean et al. Researche ...

In an interview, Andrew Kuykendall, MD, discussed fedratinib’s potential as an effective option for patients with ...

The ringing of the bell that signified the long-awaited end to the toddler’s cancer treatment was music to her parent’ ears.